36 results
8-K
EX-10.2
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing
424B4
8qr74tsl
11 Oct 22
Prospectus supplement with pricing info
8:27am
8-K
EX-1.1
2i3ro
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
8-K
EX-1.1
p6dtfz w0kk6pvaa
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm